05:15 AM EDT, 09/03/2024 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Monday a phase 3 study of investigational plozasiran in patients with familial chylomicronemia syndrome met its primary endpoint and all multiplicity-controlled key secondary endpoints. Familial chylomicronemia syndrome is a genetic disease often caused by monogenic mutations, leading to very high triglyceride levels and causing various serious symptoms....

05:00 AM EDT, 09/03/2024 (MT Newswires) -- ACI Worldwide ( ACIW ) said Tuesday it has formed a collaboration with Red Hat to make its enterprise payments platform available on any cloud infrastructure using Red Hat OpenShift. This partnership will help customers migrate to the cloud and deploy the payments platform, ACI Worldwide ( ACIW ) said. The collaboration also...

BARCELONA, Sept 3 (Reuters) - Spanish drugmaker Grifols postponed indefinitely a meeting with investors and analysts dubbed 'investors day' that was originally scheduled on Oct. 10, a document sent to investors and seen by Reuters said on Tuesday. Grifols said it made the decision in light of the potential delisting offer for Grifols' shares being evaluated by Canadian fund Brookfield...

BRUSSELS (Reuters) - Europe's top court on Tuesday backed U.S. gene sequencing company Illumina's fight against EU antitrust regulators' investigation into its $7.1 billion bid for cancer diagnostic test maker Grail. The Court of Justice sets aside the judgment of the General Court and annuls the decisions by which the Commission accepted requests from national competition authorities seeking the examination...